Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7518103 | Journal of Anesthesia History | 2017 | 40 Pages |
Abstract
The process of drug discovery and approval for clinical use has always been a lengthy, complex, and extremely expensive undertaking, with only a small minority of compounds receiving approval. The risk of adverse effects or drug interaction directly impacts commercial viability. In the case of halothane, the manufacturer disclosed major adverse effects, and the drug enjoyed decades of popularity until it was replaced by agents with a better drug profile.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Lisa Huang, Christine N. Sang, Manisha S. Desai,